Common Stock, Shares, Issued of Lexaria Bioscience Corp. from 31 Oct 2010 to 30 Nov 2025

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Lexaria Bioscience Corp. quarterly Common Stock, Shares, Issued in shares history and change rate from 31 Oct 2010 to 30 Nov 2025.
  • Lexaria Bioscience Corp. Common Stock, Shares, Issued for the quarter ending 30 Nov 2025 was 22,225,846, a 27% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

Lexaria Bioscience Corp. Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 22,225,846 +4,773,252 +27% 30 Nov 2025 10-Q 13 Jan 2026 2026 Q1
Q3 2025 19,559,179 0 0% 31 Aug 2025 10-K 28 Nov 2025 2025 FY
Q2 2025 19,559,179 +3,748,974 +24% 31 May 2025 10-Q 14 Jul 2025 2025 Q3
Q1 2025 17,559,179 +5,171,506 +42% 28 Feb 2025 10-Q 14 Apr 2025 2025 Q2
Q4 2024 17,452,594 +7,140,953 +69% 30 Nov 2024 10-Q 10 Jan 2025 2025 Q1
Q3 2024 19,559,179 +11,467,529 +142% 31 Aug 2024 10-Q 13 Jan 2026 2026 Q1
Q2 2024 15,810,205 +7,718,555 +95% 31 May 2024 10-Q 12 Jul 2024 2024 Q3
Q1 2024 12,387,673 +6,436,675 +108% 29 Feb 2024 10-Q 09 Apr 2024 2024 Q2
Q4 2023 10,311,641 +4,360,643 +73% 30 Nov 2023 10-Q 12 Jan 2024 2023 Q1
Q3 2023 8,091,650 +2,140,652 +36% 31 Aug 2023 10-K 26 Nov 2024 2024 FY
Q2 2023 8,091,650 +2,140,652 +36% 31 May 2023 10-Q 14 Jul 2023 2023 Q3
Q1 2023 5,950,998 0 0% 28 Feb 2023 10-Q 14 Apr 2023 2023 Q2
Q4 2022 5,950,998 +224,299 +3.9% 30 Nov 2022 10-Q/A 18 Jan 2023 2023 Q1
Q3 2022 5,950,998 +224,299 +3.9% 31 Aug 2022 10-K 20 Nov 2023 2023 FY
Q2 2022 5,950,998 +846,666 +17% 31 May 2022 10-Q 14 Jul 2022 2022 Q3
Q1 2022 5,950,998 +846,666 +17% 28 Feb 2022 10-Q 11 Apr 2022 2022 Q2
Q4 2021 5,726,699 +2,725,223 +91% 30 Nov 2021 10-Q 14 Jan 2022 2022 Q1
Q3 2021 5,726,699 +2,725,223 +91% 31 Aug 2021 10-K 28 Nov 2022 2022 FY
Q2 2021 5,104,332 -84,482,758 -94% 31 May 2021 10-Q 15 Jul 2021 2021 Q3
Q1 2021 5,104,332 -75,616,547 -94% 28 Feb 2021 10-Q 14 Apr 2021 2021 Q2
Q4 2020 3,001,476 -77,609,403 -96% 30 Nov 2020 10-Q 14 Jan 2021 2021 Q1
Q3 2020 3,001,476 -75,785,658 -96% 31 Aug 2020 10-K 29 Nov 2021 2021 FY
Q2 2020 89,587,090 +11,149,956 +14% 31 May 2020 10-Q 29 Jun 2020 2020 Q3
Q1 2020 80,720,879 +2,718,793 +3.5% 29 Feb 2020 10-Q 03 Apr 2020 2020 Q2
Q4 2019 80,610,879 +3,490,458 +4.5% 30 Nov 2019 10-Q 09 Jan 2020 2020 Q1
Q3 2019 78,787,134 +3,253,663 +4.3% 31 Aug 2019 10-K 15 Oct 2020 2020 FY
Q2 2019 78,437,134 +6,039,829 +8.3% 31 May 2019 10-Q 08 Jul 2019 2019 Q3
Q1 2019 78,002,086 +6,904,781 +9.7% 28 Feb 2019 10-Q 15 Apr 2019 2019 Q2
Q4 2018 77,120,421 +7,685,223 +11% 30 Nov 2018 10-Q 11 Jan 2019 2019 Q1
Q3 2018 75,533,471 +7,557,710 +11% 31 Aug 2018 10-K 14 Nov 2019 2019 FY
Q2 2018 72,397,305 +5,845,002 +8.8% 31 May 2018 10-Q 13 Jul 2018 2018 Q3
Q1 2018 71,097,305 +14,803,826 +26% 28 Feb 2018 10-Q 12 Apr 2018 2018 Q2
Q4 2017 69,435,198 +14,424,189 +26% 30 Nov 2017 10-Q 12 Jan 2018 2018 Q1
Q3 2017 67,975,761 +16,687,284 +33% 31 Aug 2017 10-K 14 Nov 2018 2018 FY
Q2 2017 66,552,303 +21,039,021 +46% 31 May 2017 10-Q 14 Jul 2017 2017 Q3
Q1 2017 56,293,479 +11,740,197 +26% 28 Feb 2017 10-Q 14 Apr 2017 2017 Q2
Q4 2016 55,011,009 +15,058,025 +38% 30 Nov 2016 10-Q 13 Jan 2017 2017 Q1
Q3 2016 51,288,477 +7,450,195 +17% 31 Aug 2016 10-K 27 Nov 2017 2017 FY
Q2 2016 45,513,282 +5,830,298 +15% 31 May 2016 10-Q 13 Jul 2016 2016 Q3
Q1 2016 44,553,282 +9,870,298 +28% 29 Feb 2016 10-Q 13 Apr 2016 2016 Q2
Q4 2015 39,952,984 +5,508,094 +16% 30 Nov 2015 10-Q 08 Jan 2016 2016 Q1
Q3 2015 43,838,282 +9,588,592 +28% 31 Aug 2015 10-K 29 Nov 2016 2016 FY
Q2 2015 39,682,984 +6,858,320 +21% 31 May 2015 10-Q 14 Jul 2015 2015 Q3
Q1 2015 34,682,984 +2,843,320 +8.9% 28 Feb 2015 10-Q 14 Apr 2015 2015 Q2
Q4 2014 34,444,890 +17,513,438 +103% 30 Nov 2014 10-Q 14 Jan 2015 2015 Q1
Q3 2014 34,249,690 +17,818,238 +108% 31 Aug 2014 10-K 27 Nov 2015 2015 FY
Q2 2014 32,824,664 +16,393,212 +100% 31 Jul 2014 10-Q 14 Nov 2014 2014 Q3
Q1 2014 31,839,664 +15,408,212 +94% 30 Apr 2014 10-Q 12 Jun 2014 2014 Q2
Q4 2013 16,931,452 +500,000 +3% 31 Jan 2014 10-Q 12 Mar 2014 2014 Q1
Q3 2013 16,431,452 0 0% 31 Oct 2013 10-KT 09 Dec 2014 2014 FY
Q2 2013 16,431,452 0 0% 31 Jul 2013 10-Q 10 Sep 2013 2013 Q3
Q1 2013 16,431,452 0 0% 30 Apr 2013 10-Q 12 Jun 2013 2013 Q2
Q4 2012 16,431,452 0 0% 31 Jan 2013 10-Q 13 Mar 2013 2013 Q1
Q3 2012 16,431,452 0 0% 31 Oct 2012 10-K 24 Jan 2014 2013 FY
Q2 2012 16,431,452 +800,000 +5.1% 31 Jul 2012 10-Q 12 Sep 2012 2012 Q3
Q1 2012 16,431,452 30 Apr 2012 10-Q 07 Jun 2012 2012 Q2
Q4 2011 16,431,452 31 Jan 2012 10-Q 13 Mar 2012 2012 Q1
Q3 2011 16,431,452 +3,505,104 +27% 31 Oct 2011 10-K 29 Jan 2013 2012 FY
Q2 2011 15,631,452 31 Jul 2011 10-Q 14 Sep 2011 2011 Q3
Q3 2010 12,926,348 31 Oct 2010 10-K 30 Jan 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.